STAT Expert Advantage
A Look at the Breast Cancer Landscape: An Expert’s Take on the Newly Approved Daiichi Sankyo Drug, ENHERTU, SGEN’s tucatinib, & the Role of IO therapy
A Look at the Breast Cancer Landscape: An Expert’s Take on the Newly Approved Daiichi Sankyo Drug, ENHERTU, SGEN’s tucatinib, & the Role of IO therapy
The NIH will raise the minimum salary for postdocs to $61,008, responding to calls from young life scientists to provide a living wage.
Congress did nothing this spring to rein in how pharmacy benefit managers operate, and the PBM industry spent big to get that result, new disclosures…
Researchers hope the pill, which will be marketed as Ojemda, may allow more patients to reach adulthood without highly toxic treatments such as radiation.
Easily a decade can pass before someone with a complex chronic condition gets a proper diagnosis. New telehealth companies aim to shorten that time and…
Donald Trump’s health care priorities remain fuzzy. But one thing is certain: A second Trump administration would put its own stamp on a host of…
The Joint Commission and the National Committee for Quality Assurance will launch updated accreditation programs for telehealth providers.
Gene therapies represent an evidence problem. Because they are just beginning to be used, little long-term data exists on their effectiveness and downstream risks.
In a scientific first, researchers have used CRISPR base editing to treat liver disease in fetal monkeys.
HHS released a final rule that would put abortion services under the same federal privacy protections as other health care data covered by HIPAA.
Confusion over Makena, a controversial failed preterm delivery drug, caused some pregnant women to receive an untested treatment.